With 1 million COVID-19 shots in just 6 days, India’s vaccination drive becomes the world’s fastest The Indian government has vaccinated nearly 16 lakh people against COVID-19 since the launch of its mass inoculation drive on January 16. According to the Health Ministry, authorities have administered approximately 10 lakh vaccine shots in just six days, ...

Individuals who are on medication that affects their immune system are advised not to take Covaxin, the developer Bharat Biotech cautioned on Monday via a factsheet. The company strongly urged people to reveal to their immunization officers about any serious health-related conditions or allergies before getting the jab.  Bharat Biotech stated that people who are ...

Indian Vaccine: The Covaxin vaccine is getting embroiled in domestic skirmish even before its delivery schedules have been put into place. The bone of contention is the fact that the vaccine has been granted emergency approval even before the human trials were completed.  There is communal disharmony over the contents of the vaccine. The main ...

Covaxin phase 1 trials: Results of phase 1 trials of Covaxin vaccine were released in a preprint paper “A Phase 1: Safety and Immunogenicity Trial of an Inactivated SARS-CoV-2 Vaccine -BBV152”. Preprint paper is a scientific manuscript version which is posted on public server before formal peer review.  The vaccine’s results propose the Covid-19 vaccine ...

SII & Bharat Biotech: India’s hopes of getting Covid-19 vaccines in a matter of days flickered away – India might have to wait just a bit longer to get a country-made vaccine rolled out for the coronavirus. Drug Controller General of India (DCGI) has put the Covid-19 vaccines Covishield and Covaxin on hold for emergency ...

First logistics blueprints: After Pfizer and Serum Institute of India approached India’s medical regulatory body DCGI seeking approval for their vaccine against Covid-19, Hyderabad-based Bharat Biotech too approached the body on Monday for approval of India’s first indigenous Covid-19 vaccine, Covaxin. Citing the progress country is making in manufacturing and procuring Covid-19 vaccine, high level ...

Potential Covid-19 vaccines: As various countries, India too is hinging its hopes on the potential Covid-19 vaccines to be authorized by the regulatory bodies for their use, especially as its one of the leading nations with maximum Covid-19 positive cases. However, out of the many vaccines under different levels of trials globally, for India the ...

Phase III clinical trials: Hyderabad based pharma giant, Bharat Biotech has announced of beginning phase III clinical trials of India’s first indigenous Covid-19 vaccine, COVAXIN. This phase will include 26,000 volunteers across 25 centres in India and is to be conducted in collaboration with the ICMR (Indian Council of Medical Research). This will make COVAXIN ...

A highly anticipated Covid-19 vaccine, COVAXIN, is being developed by Hyderabad-based Bharat Biotech in collaboration with ICMR (Indian Council of Medical Research). ICMR officials have said that the vaccine that was earlier being projected to launch only be second quarter of 2021, can now be hoped to be launched as early as February.  This is ...